Shock the heat shock network

Journal of Clinical Investigation

Volumn 119, Issue 3, 2009, Pages 445-447

  Atay, Çiǧdem ^a   Uǧurlu, Serkan ^a   Özören, Nesrin ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; BH3 PROTEIN; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMITRINIB; GELDANAMYCIN; GUANIDINE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; TRASTUZUMAB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN HCT116; CELL STRAIN MCF 7; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; DRUG MECHANISM; DRUG STRUCTURE; HELA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; METASTASIS; MITOCHONDRIAL PERMEABILITY; NOTE; PRIORITY JOURNAL; RAJI CELL; TUMOR CELL; UTERINE CERVIX CANCER; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MITOCHONDRION; NEOPLASM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CYTOCHROMES C; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; NEOPLASM PROTEINS; NEOPLASMS;

EID: 65649122232     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38681     Document Type: Note

References (18)

1. Sawyers, C. 2004. Targeted cancer therapy. Nature. 432:294-297.
2. Strausberg, R.L., Simpson, A.J., Old, L.J., and Riggins, G.J. 2004. Oncogenomics and the development of new cancer therapies. Nature. 429:469-474.
3. Slamon, D.J., et al. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:707-712.
4. Pegram, M.D., et al. 2004. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. J. Natl.Cancer Inst. 96:739-749.
5. Chen-Levy, Z., Nourse, J., and Cleary, M.L. 1989. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell. Biol. 9:701-710.
6. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., and Croce, C.M. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science. 229:1390-1393.
7. Tang, L., et al. 1998. Expression of apoptosis regulators in cutaneous malignant melanoma. Clin. Cancer Res. 4:1865-1871.
8. Sieghart, W., et al. 2006. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J. Hepatol. 44:151-157.
9. Wang, G., et al. 2006. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J. Med. Chem. 49:6139-6142.
10. Oltersdorf, T., et al. 2005. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435:677-681.
11. Vaux, D.L. 2008. ABT-737, proving to be a great tool even before it is proven in the clinic. Cell Death Differ. 15:807-808.
12. Stauffer, S.R. 2007. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737. Curr. Top. Med. Chem. 7:961-965.
13. Kang, B.H., et al. 2009. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J.Clin. Invest. 119:454-464.
14. Kang, B.H., et al. 2007. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell. 131:257-270.
15. Plescia, J., et al. 2005. Rational design of shepherdin, a novel anticancer agent. Cancer Cell. 7:457-468.
16. Beere, H.M. 2001. Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins. Sci. STKE. 2001:RE1.
17. Beere, H.M., et al. 2000. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2:469-475.
18. Solit, D.B., et al. 2008. Phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with metastatic melanoma. Clin. Cancer Res. 14:8302-8307.